title: Attribution of posttransplantation toxicity to methotrexate regarding genotype of methylenetetrahydrofolate reductase gene (MTHFR) polymorphism needs further clarification.
authors.forename: K
authors.initials: K
authors.lastname: Matsuo
authors.forename: R
authors.initials: R
authors.lastname: Suzuki
authors.forename: Y
authors.initials: Y
authors.lastname: Morishima
authors.forename: N
authors.initials: N
authors.lastname: Hamajima
mesh_terms: D005838:Genotype; D006086:Graft vs Host Disease / Q000188:drug therapy / Q000517:prevention & control; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage / Q000633:toxicity*; D042965:Methylenetetrahydrofolate Reductase (NADPH2); D009061:Mouth Mucosa / Q000382:microbiology; D000587:Oxidoreductases Acting on CH-NH Group Donors / Q000235:genetics*; D011110:Polymorphism, Genetic; D013280:Stomatitis / Q000139:chemically induced
chemical_list: D000587:Oxidoreductases Acting on CH-NH Group Donors; D042965:Methylenetetrahydrofolate Reductase (NADPH2); D008727:Methotrexate